Professor and Chair, Department of Radiology University of Kentucky, United States
Interventional Oncology is in the midst of rapid evolution, with multiple phase II/III clinical trials poised to define the role of IR therapies across tumor types. This session will highlight active and upcoming IO trials, organized by disease focus—including liver, lung, renal, metastases, and emerging or competitive spaces. Faculty will synthesize the major studies within their area, providing attendees with a clear roadmap of the current IO research landscape and insight into the pivotal results expected to shape practice in the near future.
